Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing ...

Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...

Heart failure (HF) has long been blamed on weakened heart muscle cells, but new research shows that support cells called fibroblasts may be a key factor. Researchers found that fibroblasts send ...

Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In a recent study, his group and ...

New research reveals stem cell therapy significantly lowers heart failure risk in heart attack survivors. Patients receiving ...

The nail-biting action for fans when a Dodgers pitcher stares down a Blue Jays batter is as real to the body as any other ...